泰利福 Rüsch? EZ-Blocker?一次性使用雙側支氣管堵塞器獲 NMPA 批準,...
//hzlcwl.cn2025-08-14 11:30:10 來源:全民健康網(wang)作者:美通社 PR Newswire
賓夕(xi)法(fa)尼亞州(zhou)韋(wei)恩和(he)上海2025年8月(yue)7日(ri) /美通(tong)社/ -- 泰利福公(gong)(gong)司(NYSE: TFX),全球領先的(de)醫(yi)療(liao)技術公(gong)(gong)司,今日宣布其旗下Rüsch? EZ-Blocker? 一(yi)次(ci)(ci)性(xing)使(shi)用雙側支氣管堵塞(sai)器(qi)(qi)已成功通(tong)過中國國家藥品(pin)監(jian)督管理局(NMPA)的(de)嚴格(ge)審(shen)評審(shen)批,并正式取(qu)得(de)醫(yi)療(liao)器(qi)(qi)械注冊證(注冊證編(bian)號:國械注進20252080316)。這不僅是泰利福中國產品(pin)組合的(de)一(yi)次(ci)(ci)重要升級優(you)化,更(geng)為(wei)公(gong)(gong)司在華業務的(de)增長注入強勁動力。
泰利(li)福Rüsch? EZ-Blocker?一次性(xing)使用(yong)雙(shuang)側支氣管(guan)堵塞器
泰(tai)利福中(zhong)國始終致力于為(wei)全球(qiu)醫(yi)療市(shi)場提供創新(xin)的(de)醫(yi)療解(jie)決方案(an),此次(ci) Rüsch? EZ-Blocker?一次(ci)性(xing)使用雙側支氣管(guan)堵塞器在華獲(huo)批,是泰(tai)利福深(shen)耕(geng)中(zhong)國市(shi)場、滿足(zu)中(zhong)國患者醫(yi)療需求的(de)又(you)一重要(yao)舉措(cuo)。未(wei)來,泰(tai)利福將繼續優化其(qi)在中(zhong)國的(de)產品組合(he),為(wei)推動中(zhong)國醫(yi)療健康(kang)事(shi)業(ye)的(de)發展(zhan)貢獻(xian)更多力量(liang)。
About Teleflex Incorporated
As a global provider of medical technologies, Teleflex is driven by our purpose to improve the health and quality of people's lives. Through our vision to become the most trusted partner in the world of healthcare, we offer a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. We believe that the potential of great people, purpose driven innovation, and world-class products can shape the future direction of healthcare.
Teleflex is the home of Arrow?, Barrigel?, Deknatel?, LMA?, Pilling?, QuikClot?, Rüsch?, UroLift? and Weck? – trusted brands united by a common sense of purpose.
At Teleflex, we are empowering the future of healthcare. For more information, please visit .
Forward-Looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management's current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.
Teleflex, the Teleflex logo are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries.
© 2025 Teleflex Incorporated. All rights reserved. MCC-2025-0101
Contacts:
Teleflex
Lawrence Keusch
Vice President, Investor Relations and Strategy Development
investor.relations@teleflex.com
610-948-2836
Teleflex China
Yolanda Li (李婪)
Marketing Communications Supervisor (市場傳播主管), China
yolanda.li@teleflex.com
+86 021 6060 6918
本文RSS來(lai)源(yuan):美通社
禮來中國"身體(ti)抵抗解碼展"登陸上海
意大利(li)知名正畸專家代表團訪泰康口腔(qiang) 深(shen)度研(yan)修(xiu)學習沈剛教授GS技術(shu)
以(yi)AI之(zhi)虛 強醫養之(zhi)實 構(gou)建醫康養健心(xin)AD分級(ji)防控產業(ye)生態
2025新時(shi)代骨骼健康白(bai)皮書發布(bu),推動(dong)兒童補鈣進入高(gao)含(han)量維生素(su)K2時(shi)代
勃林格殷格翰攜(xie)手澳門科技大(da)學臨床(chuang)試驗中心共建大(da)灣區臨床(chuang)研究新高地
靈活組合、高通量兼容,萬泰(tai)生物(wu)"九項呼吸道病原體核酸檢測試劑盒(he)"獲批(pi)
Eppendorf 發(fa)布全新雙按(an)鈕(niu)移液器 兼具高(gao)精(jing)度高(gao)舒適性及個性化體驗
邦耀生物(wu)成功入選"上海市市級企業技術中心",助力(li)全球(qiu)基(ji)因與細胞(bao)治療創新(xin)